- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/30 - IndolesHydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 209/30
Total number of patents in this class: 311
10-year publication summary
|
18
|
12
|
19
|
15
|
21
|
13
|
12
|
25
|
16
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 164 |
10 |
| UCB Pharma GmbH | 87 |
9 |
| LG Chem, Ltd. | 17641 |
7 |
| Cornell University | 3314 |
7 |
| Novita Pharmaceuticals, Inc. | 21 |
7 |
| Bristol-myers Squibb Company | 4881 |
6 |
| University of Tennessee Research Foundation | 754 |
5 |
| Vanderbilt University | 1908 |
5 |
| Radius Pharmaceuticals, Inc. | 50 |
5 |
| Triana Biomedicines, Inc. | 14 |
5 |
| F. Hoffmann-La Roche AG | 7945 |
4 |
| Vertex Pharmaceuticals Incorporated | 1602 |
4 |
| Kissei Pharmaceutical Co., Ltd. | 184 |
4 |
| Suven Life Sciences Limited | 135 |
4 |
| Suzhou Mednes Pharma Tech Co., Ltd. | 4 |
4 |
| AstraZeneca AB | 2897 |
3 |
| Bayer Cropscience AG | 2038 |
3 |
| Amira Pharmaceuticals, Inc. | 70 |
3 |
| Ono Pharmaceutical Co., Ltd. | 433 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2858 |
3 |
| Other owners | 210 |